文献速递肺栓塞与肺血管病

年龄与合并症对特发性肺动脉高压风险分层的影响

Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension.
PubMed 文献 · Eur Respir J · 2018-05-03

该研究纳入264例新发特发性肺动脉高压患者,按年龄分为18-45、46-64、65-74和≥75岁四组,依据欧洲心脏病学会与欧洲呼吸学会指南的风险评估工具比较基线与随访(中位5个月)风险分层变化及生存率。结果显示仅两个较年轻组风险分层显著改善,5年生存率随年龄增长而下降(18-45岁88%,46-64岁63%,65-74岁56%,≥75岁36%,p<0.001),缺血性心脏病和肾功能不全是生存的独立预测因素。

要点

  • 年轻IPAH患者风险分层可显著改善,老年组未见显著改善
  • 5年生存率随年龄增长而降低,≥75岁组仅36%
  • 缺血性心脏病和肾功能不全是生存的独立预测因素

核心结论

  • 年龄和特定合并症是IPAH患者预后的重要预测标志,应在现有风险评估算法之外加以考虑。

研究设计与样本

  • 研究纳入264例新发IPAH患者,按年龄分为18-45、46-64、65-74和≥75岁四组。
  • 依据欧洲心脏病学会与欧洲呼吸学会指南的风险评估工具确定个体风险分层。
  • 比较基线与随访(中位5个月)风险分层变化及生存率。

主要发现

  • 18-45岁组风险分层显著改善(Z=-4.613,p<0.001),46-64岁组亦显著改善(Z=-2.125,p=0.034)。
  • 65-74岁和≥75岁组风险分层未见显著改善。
  • 5年生存率:18-45岁88%,46-64岁63%,65-74岁56%,≥75岁36%(p<0.001)。
  • 缺血性心脏病和肾功能不全是生存的独立预测因素。

临床怎么用

  • 对IPAH患者进行风险分层时应结合年龄和特定合并症(如缺血性心脏病、肾功能不全)综合评估预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recent reports from worldwide pulmonary hypertension registries show a new demographic picture for patients with idiopathic pulmonary arterial hypertension (IPAH), with an increasing prevalence among the elderly.We aimed to investigate the effects of age and comorbidity on risk stratification and outcome of patients with incident IPAH.The study population (n=264) was categorised into four age groups: 18-45, 46-64, 65-74 and ≥75 years. Individual risk profiles were determined according to a risk assessment instrument, based on the European Society of Cardiology and the European Respiratory Society guidelines. The change in risk group from baseline to follow-up (median 5 months) and survival were compared across age groups. In the two youngest age groups, a significant number of patients improved (18-45 years, Z= -4.613, p<0.001; 46-64 years, Z= -2.125, p=0.034), but no significant improvement was found in the older patient groups. 5-year survival was highest in patients aged 18-45 years (88%), while the survival rates were 63%, 56% and 36% for patients in the groups 46-64, 65-74 and ≥75 years, respectively (p<0.001). Ischaemic heart disease and kidney dysfunction independently predicted survival.These findings highlight the importance of age and specific comorbidities as prognostic markers of outcome in addition to established risk assessment algorithms.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Hjalmarsson C, Rådegran G, Kylhammar D, et al. Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension. Eur Respir J. 2018. PMID: 29622568. doi:10.1183/13993003.02310-2017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。